TNPSC Thervupettagam

AdFalciVax malaria vaccine

September 14 , 2025 16 hrs 0 min 15 0
  • India has licensed Indian Immunologicals Limited, Techinvention Lifecare Private Limited, Panacea Biotec Limited, Biological E Limited, and Zydus Lifesciences to manufacture and commercialise its first indigenous multi-stage malaria vaccine.
  • The vaccine, developed by the Indian Council of Medical Research (ICMR) and its partners.
  • It targets the parasite before it enters the bloodstream, preventing transmission.
  • The vaccine, called AdFalciVax, is designed against Plasmodium falciparum and aims to minimise malaria transmission.
  • Malaria accounts for 1.4% of the global cases and 0.9% of deaths, with 95% of India’s population living in malaria-endemic areas.

 

Leave a Reply

Your Comment is awaiting moderation.

Your email address will not be published. Required fields are marked *

Categories